Showing results (51-60 of 79) with videos related to
Sort By:
Pageof 8
Iranian Journal of Public Health|October 24, 2024
Predictive Significance of Laboratory Tests in Bacteremic BrucellosisMehmet Çelik, Yeliz Çiçek, Ebru Atalay, et al.Journal of Clinical Medicine|February 13, 2026
Point-Prevalence of Antimicrobial-Related Potential Drug-Drug Interactions in Hospitalized Older Adults: A Multicenter Study Using LexicompYusuf Arslan, Esra Gürbüz, Sevil Alkan, et al.BMC Gastroenterology|May 29, 2026
The impact of metabolic dysfunction-associated steatotic liver disease on non-invasive fibrosis scores in patients with chronic hepatitis B: a multicenter retrospective studyYakup Gezer, Muhammet Rıdvan Tayşi, Arzu Tarakçı, et al.Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|November 7, 2024
Demographic, clinical and laboratory characteristics of extrapulmonary tuberculosis: Eight-year results of a multicenter retrospective study in TurkeyMehmet Celik, Esra Gurbuz, Yeliz Cicek, et al.Annals of Clinical Microbiology and Antimicrobials|February 11, 2016
Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter studyMesut Yilmaz, Nazif Elaldi, İlker İnanç Balkan, et al.BMC Infectious Diseases|May 1, 2026
The impact of previous brucellosis treatment on the clinical course of neurobrucellosis: a multicentre retrospective studyOğuz Evlice, Ezgi Yılmaz, Murat Hakan Kır, et al.Mikrobiyoloji Bulteni|January 24, 2024
[Distribution of the Prevalence of Human Leukocyte Antigen (HLA)-B*57:01 Positivity in HIV-1 Infected Individuals and Its Effects on Treatment: Türkiye Map-Buhasder Working Group]Seyit Ali Büyüktuna, Caner Öksüz, Alper Tahmaz, et al.The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|February 11, 2026
A National Multicenter Study on Initial Antiviral Treatment Preferences on Chronic Hepatitis B: Entecavir Versus Tenofovir Disoproxil FumarateTansu Yamazhan, Esra Zerdali, Yusuf Önlen, et al.International Journal of Antimicrobial Agents|January 18, 2025
Comparison of piperacillin-tazobactam and vancomycin (TZP-VAN) with piperacillin-tazobactam and teicoplanin (TZP-TEI) for the risk of acute kidney injury (CONCOMITANT): A prospective observational, multinational, multi-centre cohort studyAbdullah Tarık Aslan, Emre Kara, Gamze Köksal, et al.Infectious Diseases & Clinical Microbiology|October 14, 2024
The Efficacy of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients and the Impact of the COVID-19 Pandemic: Multicenter Real-Life DataYunus Gürbüz, Aysel Kocagül-Çelikbaş, Nefise Öztoprak, et al.Pageof 8